Fredag 9 Maj | 06:48:22 Europe / Stockholm
2025-05-07 10:33:19

Mentice has officially launched its treatment planning solution, Ankyras, in Brazil after receiving regulatory clearance from ANVISA, Brazil's National Health Surveillance Agency. According to the company, this marks a significant advancement of intracranial aneurysm care in Latin America, enabling physicians to leverage virtual rehearsal and patient-specific simulation to improve clinical outcomes.

Read the full article at biostock.se:

https://www.biostock.se/2025/05/mentice-launches-ankyras-in-brazil/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se